Answers are grounded in this paper and cite their sources.
Solid tumor growth triggers a wound healing response. Similar to wound healing, fibroblasts in the tumor stroma differentiate into myofibroblasts (also referred to as cancer-associated fibroblasts) primarily, but not exclusively, in response to transforming growth factor-β (TGF-β). Myofibroblasts in turn enhance tumor progression by remodeling the stroma. Among proteases implicated in stroma remodeling, matrix metalloproteinases (MMPs), including MMP-9, play a prominent role. Recent evidence indicates that MMP-9 recruitment to the tumor cell surface enhances tumor growth and invasion. In the present work, we addressed the potential relevance of MMP-9 recruitment to and activity at the surface of fibroblasts. We show that recruitment of MMP-9 to the fibroblast cell surface occurs through its fibronectin-like (FN) domain and that the molecule responsible for the recruitment is lysyl hydroxylase 3 (LH3). Functional assays suggest that both pro- and active MMP-9 trigger α-smooth muscle actin expression in cultured fibroblasts, reflecting myofibroblast differentiation, possibly as a result of TGF-β activation. Moreover, the recombinant FN domain inhibited both MMP-9-induced TGF-β activation and α-smooth muscle actin expression by displacing MMP-9 from the fibroblast cell surface. Together our results uncover LH3 as a new docking receptor of MMP-9 on the fibroblast cell surface and demonstrate that the MMP-9 FN domain is essential for the interaction. They also show that the recombinant FN domain inhibits MMP-9-induced TGF-β activation and fibroblast differentiation, providing a potentially attractive therapeutic reagent toward attenuating tumor progression where MMP-9 activity is strongly implicated. Background: MMP-9 cell surface activity promotes tissue remodeling. Results: Fibroblast cell surface recruitment of MMP-9 via its fibronectin-like domain (FN) by lysyl hydroxylase 3 (LH3) induces TGF-β activation and myofibroblast differentiation. Conclusion: We identify a novel mechanism of MMP-9 recruitment to stromal cells that can be modulated by recombinant FN. Significance: Recombinant FN may allow selective MMP-9 blockade in tumor-associated tissue remodeling.
No takes yet. Share an insight, caveat, or question.
Dayer et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: